how were glp 1 drugs discovered The discovery and development of GLP-1 based that have revolutionized the treatment of obesity GLP-1 Receptor Agonists as Treatments
Description
doi: 10.2165/00128071-200506050-00003
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int
10.2337/dc14-1142 [DOI] [PubMed] [Google Scholar] 80.Mathieu C, Ranetti AE, Li D, Ekholm E, Cook W, Hirshberg B, et al
Novel, in-vivo and in vitro data suggest that exenatide, a GLP-1 receptor agonist, may represent an ideal therapy for IIH through rapid reduction of CSF secretion at the choroid plexus, lowering ICP in addition to its weight loss properties
A1C reductions were largely maintained over time
The impact of exenatide on cognitive function in patients with raised ICP has not been explored
